Insider Transactions Reported by 14 Insiders of Aspire Biopharma Holdings, Inc.

Symbol
ASBP, ASBPW on Nasdaq
Location
Estero, FL

There are no Buy or Sell transactions made by insiders since 15 Mar 2025

Aspire Biopharma Holdings, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Donald G. Fell Director $7,800 $0 0% 04 Jun 2025
Surendra K. Ajjarapu Chief Executive Officer, Director, 10%+ Owner 18 Aug 2023
Michael L. Peterson Director 18 Aug 2023
Howard A. Doss Chief Financial Officer 18 Aug 2023
Bruce L. Hack Director 17 Feb 2022
PowerUp Sponsor LLC 10%+ Owner 18 Aug 2023
Mayur Mansukhlal Doshi Director 18 Aug 2023
Peter Blacklow Director 17 Feb 2022
Jack Tretton Chief Executive Officer, Director 17 Feb 2022
Julie Uhrman Director 17 Feb 2022
Avinash R. Wadhwani Director 18 Aug 2023
Gabriel Schillinger President 17 Feb 2022
Michael J. Olson Chief Financial Officer 17 Feb 2022
Kyle Joseph Campbell Director 16 May 2022

Recent Insider Transactions by Companies or Individuals for Aspire Biopharma Holdings, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Donald G. Fell ASBP Common Stock, par value $0.0001 Purchase 110.5% $4,095 $0.3900 10,500 20,000 05 Jun 2025 Direct
Donald G. Fell ASBP Common Stock, par value $0.0001 Purchase -34.4% $4,095 $0.3900 -10,500 20,000 05 Jun 2025 Direct
Donald G. Fell ASBP Common Stock, par value $0.0001 Purchase $3,705 $0.3900 9,500 9,500 04 Jun 2025 Direct
Donald G. Fell ASBP Common Stock, par value $0.0001 Purchase -50% $3,705 $0.3900 -9,500 9,500 04 Jun 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.